A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine

From the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD (JBR, RS), and The Rockefeller University, New York, NY (ECG). Accepted for publication July 21, 2000. Address for reprints: John B. Robbins, M.D., National Institutes of Health, Building 6, Room 424, Bethesda, MD 20892. E-mail [email protected] The authors have no financial conflict of interest in espousing the routine use of meningococcal polysaccharide vaccines.